期刊文献+

阿司匹林对兔动脉粥样硬化及其炎性过程的影响 被引量:4

Effects of Aspirin on Atherosclerosis and Its Inflammation Process in Atherosclerotic Rabbits
下载PDF
导出
摘要 目的探讨阿司匹林对兔动脉粥样硬化及其炎性过程的影响。方法18只雄性新西兰兔随机分为对照组(喂食普通兔饲料)、高脂模型组(喂食高脂饲料)、阿司匹林组(喂食高脂饲料并给予阿司匹林干预),饲养12周后处死动物,取主动脉进行病理学检查,采用免疫组化SP方法观察各组斑块区环氧合酶2(COX-2)的表达、巨噬细胞和平滑肌细胞的数量变化。结果病理学大体观察,对照组、高脂模型组和阿司匹林组斑块/内膜面积比分别为0、(59.6±13.7)%和(49.3±7.8)%,组间比较差异有极显著性意义(P<0.01);光镜下动脉粥样硬化斑块多参数分析显示,斑块最大厚度、管腔狭窄度和斑块所占周径比值3个指标各组间两两比较差异均有极显著性意义(P<0.01)。免疫组化检测结果显示:阿司匹林组斑块区COX-2表达、巨噬细胞数量明显低于高脂模型组,平滑肌细胞增殖和迁移也低于高脂模型组。结论阿司匹林能明显减轻高脂饮食所致的动脉粥样硬化大小及程度。抑制斑块内COX-2的表达以及后续的炎症过程可能是其抗动脉粥样硬化的机制之一。 Objective To examine the effects of aspirin on atherosclerosis and its inflammation process in atherosclerotic rabbits. Methods Eighteen male New Zealand rabbits were randomly divided into 3 groups: control group, untreated cholesterol-fed group, aspirin-treated group, which were fed for 12 weeks. After 12 weeks, the aorta was harvested for pathologic morphology observation. By using immunohistochemistry, the expression of COX-2 and the changes in number of macrophages and vascular smooth muscle cells (VSMCs) were observed. Results The aorta plaque/intima size (P/I) was 0, (59.6±13.7)% and (49.3±7.8)% in control group, untreated cholesterol-fed group and aspirin-treated group respectively by pathologic morphology observation (P〈0.01). The maximum plaque thickness, the degree of artery stenosis and the proportion of the intimal circumference occupied by atheroma in 3 groups were different from each other significantly (P〈0.01). The expression of COX-2, the number of macrophages and the VSMCs proliferation and migration from media to intima in the plaque of aspirin-treated group were decreased as compared with those in untreated cholesterol-fed group. Conclusion Aspirin can suppress the progression of experimental atherosclerosis and stabilize the plaque. The expression of COX-2 in plaque was also decreased after aspirin treatment, which may be one of the mechanisms by which aspirin suppresses the progression of experimental atherosclerosis.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2008年第4期486-489,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
关键词 阿司匹林 动脉粥样硬化 环氧合酶2 aspirin, atherosclerosis, cyclooxygenase-2
  • 相关文献

参考文献14

二级参考文献56

  • 1刘艳英,刘永铭,杨京港,严祥.高脂血症患者血清补体C3、C4、备解素和白细胞补体调节蛋白CD35、CD55、CD59的表达[J].中国循环杂志,2005,20(3):176-179. 被引量:9
  • 2刘永铭,严祥,刘艳英.补体与动脉粥样硬化[J].中华心血管病杂志,2005,33(9):866-869. 被引量:21
  • 3脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15764
  • 4Ylitalo K,Pajukanta P,Meri S,et al.Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia.Arterioscler Thromb Vasc Biol,2001,21:838-843. 被引量:1
  • 5Mason JC,Yarwood H,Sugars K,et al.Induction of decay-accelerating factor by cytokines or the membrane-attack complex proteins protects vascular endothelial cells against complement deposition.Blood,1999,94:1673-1682. 被引量:1
  • 6Meijssen S,van Dijk H,Verseyden C,et al.Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia.Aterioscler Thromb Vasc Biol,2002,22:811-816. 被引量:1
  • 7Niculescu F,Rus HG,Vlaicu R.Decay-accelerating factor regulates complement-mediated damage in the human atherosclerotic wall.Immunol Lett,1990,26:17-23. 被引量:1
  • 8Serfert PS,Roth I,Schmiedt W,et al.CD59(homologous restriction factor 20),a plasma membrane protein that protects against complement C5b-9 attack in human atherosclerotic lesions.Atherosclerosis,1992,96:135-145. 被引量:1
  • 9Rooney IA,Morgan BP.Protection of human amniotic epithelial cells(HAEC) from complement-mediated lysis:expression on the cells of three complement inhibitory membrane proteins.Immunology,1990,71:308-311. 被引量:1
  • 10Miner JL.The adipocyte as an endocrine cell.J Anim Sci,2004,82:935-941. 被引量:1

共引文献205

同被引文献41

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部